Free Trial
NYSE:MDT

Medtronic (MDT) Stock Price, News & Analysis

Medtronic logo
$88.16 +0.99 (+1.13%)
As of 12:45 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Medtronic Stock (NYSE:MDT)

Key Stats

Today's Range
$86.71
$88.65
50-Day Range
$80.70
$88.47
52-Week Range
$75.96
$96.25
Volume
2.74 million shs
Average Volume
6.95 million shs
Market Capitalization
$113.07 billion
P/E Ratio
24.36
Dividend Yield
3.22%
Price Target
$97.87
Consensus Rating
Moderate Buy

Company Overview

Medtronic plc (NYSE: MDT) is a global leader in medical technology, dedicated to developing innovative therapies that improve the health and lives of millions of people around the world. The company specializes in devices and solutions across a broad spectrum of medical specialties, including cardiac rhythm management, diabetes management, restorative therapies, minimally invasive therapies, and surgical technologies. Medtronic’s offerings are designed to address chronic diseases and complex medical conditions, enabling healthcare providers to deliver more effective patient care.

Medtronic’s product portfolio includes implantable cardiac pacemakers, defibrillators, heart valves and stents, insulin pumps and continuous glucose monitoring systems, and neurological and spinal therapies. The company also provides advanced surgical instruments and robotic-assisted surgical platforms, as well as ENT and respiratory care solutions. By integrating digital health tools and data analytics, Medtronic aims to enhance procedural efficiency, improve patient outcomes and reduce the overall cost of care.

With operations in more than 150 countries, Medtronic maintains a diverse geographic presence, serving hospitals, clinics and surgical centers across the Americas, Europe, Asia, Africa and Australia. The company invests heavily in research and development, operating multiple R&D centers worldwide to foster collaboration with physicians, academic institutions and research organizations. This global footprint enables Medtronic to tailor its products to meet regional healthcare needs while remaining at the forefront of medical innovation.

Founded in 1949 by Earl Bakken and Palmer Hermundslie in Minneapolis, Medtronic has grown from a small medical equipment repair shop into one of the largest medtech companies in the world. Headquartered in Ireland with principal executive offices in the United States, Medtronic is led by Chairman and CEO Geoff Martha. Under his leadership, the company continues to pursue strategic acquisitions and partnerships, reinforcing its commitment to advancing the treatment of chronic diseases and improving patient quality of life.

AI Generated. May Contain Errors.

Medtronic Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

MDT MarketRank™: 

Medtronic scored higher than 97% of companies evaluated by MarketBeat, and ranked 34th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medtronic has received a consensus rating of Moderate Buy. The company's average rating score is 2.63, and is based on 8 buy ratings, 9 hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Medtronic has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Medtronic's stock forecast and price target.
  • Earnings Growth

    Earnings for Medtronic are expected to grow by 6.78% in the coming year, from $5.46 to $5.83 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medtronic is 24.38, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 24.80.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medtronic is 24.38, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.40.

  • Price to Earnings Growth Ratio

    Medtronic has a PEG Ratio of 2.32. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Medtronic has a P/B Ratio of 2.35. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Medtronic's valuation and earnings.
  • Percentage of Shares Shorted

    0.66% of the float of Medtronic has been sold short.
  • Short Interest Ratio / Days to Cover

    Medtronic has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medtronic has recently increased by 7.49%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Medtronic pays a meaningful dividend of 3.30%, higher than the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Medtronic has been increasing its dividend for 49 years.

  • Dividend Coverage

    The dividend payout ratio of Medtronic is 78.45%. Payout ratios above 75% are not desirable because they may not be sustainable.

  • Dividend Sustainability

    Based on earnings estimates, Medtronic will have a dividend payout ratio of 48.71% next year. This indicates that Medtronic will be able to sustain or increase its dividend.

  • Read more about Medtronic's dividend.
  • Percentage of Shares Shorted

    0.66% of the float of Medtronic has been sold short.
  • Short Interest Ratio / Days to Cover

    Medtronic has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Medtronic has recently increased by 7.49%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Medtronic has a news sentiment score of 1.29. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.90 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 63 news articles for Medtronic this week, compared to 36 articles on an average week.
  • Search Interest

    Only 48 people have searched for MDT on MarketBeat in the last 30 days. This is a decrease of -2% compared to the previous 30 days.
  • MarketBeat Follows

    Only 25 people have added Medtronic to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medtronic insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.20% of the stock of Medtronic is held by insiders.

  • Percentage Held by Institutions

    82.06% of the stock of Medtronic is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medtronic's insider trading history.
Receive MDT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medtronic and its competitors with MarketBeat's FREE daily newsletter.

MDT Stock News Headlines

Dividends claw machine game - This image is an original composition by MarketBeat using licensed and editorial elements. Not for redistribution or reuse.
3 Safe Buy-and-Hold Dividend Stocks With Strong Balance Sheets
These 3 dividend stocks offer strong balance sheets, low debt, and reliable payouts, making them solid long-term picks for income investors...
Medical technology with 3d rendering robotic assisted surgery with mock up model in operating room — Photo
Intuitive Surgical: Profit or Peril Ahead Amid Trade & Turf Wars? (MDT)
Intuitive Surgical has soared over 150% in three years. But, can the healthcare stalwart overcome tariffs and rising competition to continue winning long-term?
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
Medtronic: Margin Inflection With Diabetes Spin - Key Drivers
See More Headlines

MDT Stock Analysis - Frequently Asked Questions

Medtronic's stock was trading at $79.88 on January 1st, 2025. Since then, MDT shares have increased by 10.6% and is now trading at $88.3420.
View the best growth stocks for 2025 here
.

Medtronic PLC (NYSE:MDT) announced its quarterly earnings results on Wednesday, May, 21st. The medical technology company reported $1.62 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.58 by $0.04. The company's quarterly revenue was up 3.9% on a year-over-year basis.
Read the conference call transcript
.

Top institutional investors of Medtronic include Cullen Investment Group LTD. (0.01%). Insiders that own company stock include Geoffrey Martha, Sean Salmon, Gregory L Smith, Hoedt Rob Ten, Brett A Wall and Michael Marinaro.
View institutional ownership trends
.

Shares of MDT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medtronic investors own include JPMorgan Nasdaq Equity Premium Income ETF (JEPQ), Symbotic (SYM), Meta Platforms (META), NVIDIA (NVDA), Chevron (CVX), Verizon Communications (VZ) and Broadcom (AVGO).

Company Calendar

Record date for 4/11 Dividend
3/28/2025
Ex-Dividend for 4/11 Dividend
3/28/2025
Dividend Payable
4/11/2025
Last Earnings
5/21/2025
Record date for 7/11 Dividend
6/27/2025
Ex-Dividend for 7/11 Dividend
6/27/2025
Today
6/30/2025
Dividend Payable
7/11/2025
Next Earnings (Estimated)
8/19/2025
Fiscal Year End
4/30/2026

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Health Care Equipment
Current Symbol
NYSE:MDT
Employees
95,000
Year Founded
1949

Price Target and Rating

Average Stock Price Target
$97.87
High Stock Price Target
$110.00
Low Stock Price Target
$87.00
Potential Upside/Downside
+12.2%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.63
Research Coverage
19 Analysts

Profitability

Trailing P/E Ratio
24.10
Forward P/E Ratio
15.98
P/E Growth
2.32
Net Income
$4.66 billion
Pretax Margin
16.78%

Debt

Sales & Book Value

Annual Sales
$33.54 billion
Cash Flow
$7.86 per share
Price / Cash Flow
11.10
Book Value
$37.62 per share
Price / Book
2.32

Miscellaneous

Outstanding Shares
1,282,540,000
Free Float
1,279,978,000
Market Cap
$111.90 billion
Optionable
Optionable
Beta
0.79

Social Links

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report

This page (NYSE:MDT) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners